1. Project
  2. Allo-THYTECH
  3. Organisations

Development and implementation in clinical practice of the allogeneic use of thymus-derived regulatory T cells (thyTreg) as a cell therapy to suppress harmful immune responses

Full project page

Organisations map overview


Powered by Chris Decubber BV